FOX-04 DRI

FOXO4-DRI is a synthetic peptide that selectively targets and eliminates senescent “zombie cells” by disrupting the interaction between the FOXO4 protein and the p53 tumor suppressor, thereby inducing apoptosis in aged, dysfunctional cells while sparing healthy tissue.

Key benefits identified in research and clinical protocols include:

• Anti-Aging & Tissue Regeneration: By clearing senescent cells, the peptide reduces chronic inflammation and oxidative stress, which has been shown to restore kidney function, improve fur density, and enhance physical stamina in aged mice.
• Hormonal Restoration: Studies indicate the peptide can alleviate age-related testosterone insufficiency by removing senescent Leydig cells in the testes, potentially reversing male late-onset hypogonadismwithout the need for exogenous testosterone.
• Cancer & Chemotherapy Support: FOXO4-DRI has demonstrated the ability to neutralize chemotherapy-induced toxicity (such as Doxorubicin damage) and may serve as an adjunct therapy for certain forms of cancer by targeting senescent cells that contribute to tumor survival or drug resistance.
• Organ Health: The peptide promotes cellular rejuvenation and tissue homeostasis, potentially aiding in the recovery of tissues damaged by aging or medical treatments, including improved mitochondrial functionand neurological health.